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Introduction: Melissa officinalis is usually used as antispasmodic, antiaxiety and antibacterial agent. 
However, its toxicity has not been evaluated, yet. In this study biochemical, liver and renal toxicities of 
Melissa officinals hydroalcoholic extract were evaluated in balb/C mice. 
Methods: In an experimental study, 21 balb/C male mice were randomly designated to three equal 
groups. Group I was treated with normal saline and groups II and III were respectively treated with 0.450 
and 1.350 g/kg, hydroalcoholic extract of Melissa officinals daily for two weeks, intraperitoneally. Then 
on 15th day of the experiment, blood samples were obtained from the heart. The blood was centrifuged 
and then the sera were evaluated for alanine aminotransferase, aspartate aminotransferase, alkaline 
phosphatase, urea and creatinine, using autoanalyzer and commercial kits. The liver and kidney tissues 
were also hystopathologically evaluated. The data were analyzed by one-way ANOVA, Tukey’s post hoc 
test, and Kruskal-Wallis at a significance level of p<0.05.
Results: Melissa officinals dose dependently caused a significant reduction in alkaline phosphatase and 
alanine aminotransferase levels compared to the control group. Furthermore, Melissa officinals extract 
had no effect on the amount of urea and creatinine compared to the control group. The liver and 
kidney histopathological changes in the groups that received different doses of the extract showed mild, 
moderate, and severe tissue injuries.
Conclusion: The biochemical analysis in this study indicates that the extract of Melissa officinals causes 
liver tissue damage in mice; therefore, its consumption in high doses should be avoided. 
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Introduction
The use of herbal medicines has been increased in the last few 
decades due to some properties such as variety of chemical 
biologic activities, effectiveness, higher safety and lower cost 
in comparison to synthetic drugs (1,2). In Iran the use of 
herbal medicine in the treatment of deseases is developing 
but biologic active compounds effects of some plant species 
on human health has been remained unknown. Melissa 
officinalis (lemon balm) with scientific is a medicinal plant in 
Lamiaceae family. It is more than 2 thousand years that this plant 
has been known. This plant grows in some mediterean regions, 
most Euroupean countries, Central America (3), and widely in 
Tehran, Golestan, Azarbayjan, Lorestan and Kermanshah (4,5). 
In traditional Iranian medicine the lemon balm has been used in 
the treatment of depression and to reduce nervousness in young 
daughters (5). Most common therapeutic properties of the 
lemon balm are sedative, antioxidant, antispasm, antibacterial, 
antivirus, anti inflammation properties (6). It is also used dor the 
treatment of stomach disorders, histria, migraine, toothache, 
headache, hypertension, rheumatism, neuralgia, stiff neck 
(7), relief of menstrual cramps and relief of fever caused by 
cold (3). Today this plant is commonly used in cosmetics, 
perfumary and food industries (3). Experimental studies on 
laboratory animals have shown that hydroalchohol extract of 
the lemon balm plant has calming effect on central nerveous 
sytem. On the other hand this plant reacts to some drugs 
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like alchohol, tranquilizers, barbiturates, antigaluocoma 
drugs and selective serotonin reuptake inhibitors (4). More 
than one hundred chemicals have been identified available 
in lemon balm. Some herbal chemicals like jeraniol linalool, 
citronella and citral produce perfume and fragnance in lemon 
balm (8). Moreover lemon balm plant contains a number 
of flanovoids and monoterpenoid aldehydes (6). Some of 
phenolic compounds are tannins, rosmarinic acid, fanovids 
like apigenin-7-oxide-glucoside, luteolin-7-oxide-glucoside 
and three flavenoids including Rhamnazin, ramnocitrin and 
isoquercetin (8,9).  The results of the last studies have shown 
that lemon balm extract contains rosmarinic acid, tritrepnoids, 
olinolic acid and oresal acid that prvent the activities of 
gamma-amminobutric acid transaminase (GABA-T) (10) 
and this prevention increase brain accessability to GABA 
(11). Given lemon balm pharmaceutical properties, studying 
the toxic effects of this plant is significantly important. The 
present study is the first experimental study that considers 
effect of subacute toxicity of lemon balm hydroalcoholic extract 
on liver and kidney tissues of the female balb/C mice in the terms 
of anzyme changes and pathology in order to show side effects that 
can be provided following consumption of this plant. 
Materials and Methods
In this experimental study lemon balm samples were provided 
from grossary centers were confirmed by botenists of the 
Medical plants research Center of the Shahrekord University 
of Medical Siences. Then, a herbarium specimen was prepared 
and kept in Herbarium unit of Shahrekord University of 
Medical Sciences under No. 407. The maceration method was 
used to extract lemon balm plant. Smooth powder was made 
form dried leaves and branches of the plant by using an electric 
mill. Then, the powder was mixed with 70 degree alchohol to 
the extent that alchohol level was 3 centimeters higher than 
powder level and then this mixture was filtered using glass 
hopper and filter paper after passing 48 hours. Filtered solution 
was transferred into balloon and its solvent was evaporated by 
rotary vaccuim pump (set in 48-50 ċ). Obtained concentrated 
liquid was dried by a flat glass dish inside avon in 37 °C. 
The obtained powder was collected to be used in providing 
different doses of lemon balm hydroalchoholc extract (6,12). 
40 grams pure lemon balm extract was obtained from 1000 gr 
dried lemon balm plant. In this interventional study albino 
female mice with approximate weight of 20-30 g were used 
to conduct study. They were provided from Tehran Pastor 
Institute and then maintained in laboratory Animals Resource 
Center of the Islamic Azad University of Shahrekord in 3±20 
ċ, 12 hours light-dark cycle and appropriate humidity. To 
make them compatible with environmental conditions mice 
were randomly divided into three groups of seven mice, one 
week befor starting the test, including a control group and two 
treatment groups treated with 0.450 and 1.350 mg/kg doses 
of lemon balm hydroalcoholic extract and were maintained 
in standard polipropolyne cages. Urban water and standard 
pelleted food were freely available for mice. All instructions 
related to work with laboratory animals were performed in 
accordance with University Regulation and Ethics Committee 
orders. To determine acute toxity (LD50) with regard to similar 
studies 18 other female mice were divided into three groups 
of six mice which received 4, 4.5 and 5g /Kg doses of lemon 
balm hydroalchoholic extract, intraperitoneally. Mice were 
cared and supervised for 5 hours at 2.30 h intervals and for 
24h at the end of experiment in terms of behaviour, food and 
water consumption amount and death. Mortality number was 
determined after 24h (12) and LD50 was obtained 4.5 g/Kg. 
After specification of acute toxicity dose the studied groups 
were injected daily with lemon balm hydroalcoholic extract 
at 10 and 30% doses of acute toxicity, respectively for 14 days 
at a same time and control group was injected 0.3 ml normal 
saline, intraperitoneally (6). Mice were not fed for 12 hours 
after last injection of hydroalcoholic extracts and normal 
salin then blood samples were collected from the heart after 
anesthetization by chloroform and opening thoracic cavity. 
To seprate serum, the sample was centrifuged 10 minutes 
in 3000 cycles. Measurment of ALP, ALT and AST enzymes 
and serum levels of urea and creatinine was performed by 
autoanalyzer BT-3000 model (Biotechnique Company, Italy) 
using diagnostic kits of the Pars Azmoun Company. To 
perform pathology studies liver and kidney tissue samples 
were fixed in 10% buffered formalin (German country). Then 
according to common histology methods paraffin blocks were 
provided and some 5 micron cuts were created by microtom 
Shandon Citadel 315 model (England) and then were stained 
with haematoxylin and eosin (13). Damages of the kidney 
and liver tissue in studied groups were randomly selected 
with magnification 100, in three microscope fields and then 
were studied. These demages included some abnormalities 
in structural order and pattern of the liver cells and kidney 
nephrons. Results were reported as (-), (+), (+2) and (+3) 
signs, respectively for no changes in the kidney and liver 
structural order, presence of  mild focal amnormalities in 
the liver lobules and kidney tubules structure and order, 
50% (moderate) abnormality in the liver lobules and kidney 
tubules and sever abnormality in liver and kidney structure. 
The signs -, +, +2 and +3 were used respectively to show lack 
of observation of  the ducts with hyperplastic epithelial cells, 
observation of three biliary tracts  in each triads, 4 or 5 ducts 
with connective tissue in each triad and more than 5 biliary 
ducts in each triad, respectively. Lack of piecemeal necrosis 
around the portal area and the glomerular tubules, mild 
piecemeal necrosis, less than 50% involvement (moderate) 
of the hepatocytes around the portal tract and the curved 
pipes near and around the cortical area and more than 50% 
involvement of  the hepatocytes around the portal tract and 
the cortical tubules  were  considered, respectively as  signs  -, 
+, +2 and +3. Lack of inflammatory cells observation in the 
portal area and between kidney  tubules was reported with 
sign  -, mild penetration of inflammatory cells in less than 1/3 
of  the portals and  between renal tubules was reported with 
sign +, moderate penetration of inflammatory cells in the 1/3 
to 2/3 of portals and between renal tubules was reported with 
sign +2 and sever penetration  of compressed  inflammatory 
cells in more than 2/3 of the portal area and between renal 
tubules was reported with sign +3. The signs -, +, +2 and 
+3 were assigned respectively to lack of portal fibrosis 
observation, development of mild portal fibrosis, moderate 
fibrous bridges and severe cirrhosis. Neutrophils accumulation 
in dead liver cells regions was defined as hepatocyte focal 
necrosis. Also apoptotic hepatocytes were specified by 
acidophilic cytoplasm and hyalinization. The presence of focal 
liver and renal toxicities of Melissa officinals
37Journal of HerbMed Pharmacology, Volume 2, Number 2, December 2013http://www.herbmedpharmacol.com    
necrosis, diffuse necrosis, apoptosis, Kupffer cells hyperplasia, 
sinusoidal dillation and hyperemia was specified with the 
sign + and the sign – was used to show their absence (14). 
Based on the results obtained from the Kolmogorov-Smirnov 
test to estimate equality of continuous, one-dimensional 
probability distribution, all data were distributed normally 
(P>0.05). Data were presented as mean±standard deviation 
and the one-way ANOVA statistical test was used to test 
significant difference between control and treatment groups. 
The Tukey’s Post Hoc test was used if significant difference 
was obtained. Also to test histopathological data, the data 
obtained as qualitative between groups were analysed by 
Kruskal-Wallis test using SPSS statistical software.
Resuls
The results of biochemical parameters tests showed that 
serum activity of enzyme AST, as well as creatinine and urea 
following intraperitoneal injection of 450 and 1350 mg/kg 
doses of lemon balm had not changed significantly compared 
to control group (P>0.05), but the enzyme ALT in groups 
of mice treated with 1.350 g/kg dose of lemon balm extract 
showed significant reduction compared to control group and 
group of 450 mg /kg dose of lemon balm (P<0.05). Also activity 
of ALP enzyme in groups treated with hydroalcoholic lemon 
balm extract at doses of 10 and 30% acute toxicity showed a 
significant decrease (P<0.01) compared to the control group 
(Table 1).
According to  histopathologic results  of  the liver tissue the 
lemon balm has increased relatively mild  the pleomorphism 
hepatocyts in group  recieving  30%  lemon balm  compared 
to other groups (P<0.05). Also in group receiving 30% 
lemon balm, moderate necrosis of the liver parenchymal, 
sinusoids dilation and moderate  increase of  hepatocytes 
with eosinophilic cytoplasm and  hyperchoromatic chromatin 
(apoptosis)  was more than the other groups  (P<0.05) (Table 
2 and Figure 1). 
Microscopic studies conducted on liver tissue in groups 
receiving  lemon balm at doses of 10 and 30% acute toxicity 
showed secretion of mononuclear inflammatory cells in the 
portal space (Figure 1),  irregular hepatocytes plates  and 













Control 49±11.91 0.08 0.42 ± 360.2±89.15 44.8±5.07 180.8±53.28
Group 10% 42.6±11.12 0.050.36 ± **185.2±38.48 34.4±5.36 131±29.93
Group 30% 40.33±9.33 0.040.38± **148.17±54.03 *27.33±7.84 137.67±22.1
The number of mice in each group was 7, the data are as Mean ± SD, 
*P<0.05 compared to control group, **P <0.01 compared to control group.
Table 2. Intensity of  histopathological changes in liver tissue of the albino mice in  different doses of lemon balm
Groups
Liver changes Lemon balm 10% P value Control Lemon balm 30%
Hepatocytes degenerations 2+ 0.001 + 2+
Sinusoidal congestion - 0.389 - +
Sinusoidal dilatation - 0.032 - 2+
Portal  congestion + 0.147 - +
Portal dilatation 2+ 0.114 + 3+
Liver vein blood + 0.082 - 2+
Bile ducts proliferation - 1.00 - -
Mononuclear cell secretion around the central vein + 0.411 - +
Mononuclear cell secretion around  the portal area 2+ 0.035 + 2+
Poleomorphism hepatocytes - 0.047 - +
Distinct nucleoli in hepatocytes 2+ 1.00 2+ 2+
Hepatocytes with eosinophilic cytoplasm + 0.042 + 2+
Necrosis of the liver parenchymal cells 2+ 0.002 - 2+
Irregular plates + 0.026 - +
Increase of fibrous tissue around the portal area - 0.876 - +
- Lack of histological changes observations (normal structure), + mild damage, 2+ moderate damage, 3+ sever damage
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Figure 1. Histopathological picture of  the liver in  lemon balm group.
Right side shows  secretion of the lymphocytic cells  in the portal space 
(arrow) and dilation of  portal vein, apoptic cells (arrow peak), (H & E 
× 250); left side shows liver lobules  structure in the control group, 
central vein  (dark arrow) and natural hepatocytes  (light arrow), (H 
& E × 400).
liver paraenchymal necrosis than  control group (P<0.05). 
Histopathologic results of  the kidney tissue in group receiving 
lemon balm at dose of 30% of acute toxity showed relatively 
mild  atrophy of the glomerulus, and increase in  urinary 
space than other groups (P<0.05) (Figure 2 and Table 3).
Figure 2. Histopathological image of the kidney tissue in the group 
receiving 30 %  acute toxicity lemon balm.
Right side: Atrophy of the kidney tubules and glomeruli (arrow), (H & 
E × 250); leftside: tubules structure (dark arrow) and kidney glomeruli 
(light arrows) in control groups (H & E × 400).
Discussion
Liver enzymes such as ALT, AST, GGT and ALP are enzymes 
that significantly reflect liver hepatocytes  necrosis and 
cholestasis and can be used in detection of sever liver diseases 
such as liver inflammation (15,16). Enzyme ALT in dog, cat, 
rabbit and rat is a liver  hepatocyte cytosol specific enzyme 
that is increased in blood plasma in result of change in liver 
activity (17). In addition, AST has been recommended to 
identify liver abnormalities (17). ALP is a membrane-bound 
glycoprotein enzyme found in different tissues such as liver, 
bone and in kidney, intestine and placenta in less amounts. 
Also, it is a valuable biochemical  index used in detection of 
hepatobiliary disorders, osteoporosis, and fatty liver disease 
(18,19). In this research, the acivity of ALT  enzyme in 
group recieving 1350mg/kg lemon balm showed significant 
decrease compared to  control group and injection of 450 
and 1350 mg/kg doses of lemon balm hydroalcoholic extract 
decreased significantly enzyme ALP compared to control 
group. Researches of Wei et al showed that apigenin had 
anti-tumor properties, especially on breast tumors (13,14), 
and prevent Ornithine decarboxylase activity (20). Le Bail 
et al also presented the effective role of apigen in preventing 
activity of aromatase (human estrogen synthetase) and 17- 
Beta hydroxysteroid dehydrogenase available in the human 
placental microsomes (21). On the other hand change in the 
activity of liver aminotransferases encourages the renovation 
of glucose from amino acids and changes activity of plasma of 
AST and ALT. Activity of these two enzymes can be changed 
with a variety of chemical and biological substances and 
physiological factors or disorder in Krebs cycle. Decreased 
activity of the Krebs cycle causes decrease in some compounds 
and finally decreases in AST and ALT (22). It seems that 
decrease in activity of ALT and ALP enzymes in treatment 
groups is due to presence of apigenin compound that prevents 
activity of the ATP precursors and aminoteransferses. This 
hypothesis needs more studies. Histopathological changes of 
liver tisuue in groups receiving 450 and 1350 mg/kg doses of 
Table 3. Intensity of histopathological changes in the kidney tissue of the albino mice in the different doses of lemon balm  
Groups
Changes in kidney tissue     
P value Control Lemn balm   30% Lemn balm   10%
Degeneration of tubular epithelial cells 0.095 + 2+ +
Tubular epithelial cell necrosis 0.073 - + +
Glomerular atrophy 0.029 - + -
Tubules atrophy 1.00 - - -
Protein secretion in the tubules 1.00 - - -
Mononuclear cell secretion around the interstitial tissue 0.45 - - -
Increase in fibrous tissue 0.45 - - -
Glomeruli congestion 0.92 + + +
Vascular congestion in interstitial tissue 0.17 - + -
Renal venous congestion 0.32 + + 2+
- Lack of histological changes observation (normal structure), + mild damage, moderate damage, +2, +3 sever damage.
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lemon balm showed that presence of eosinophilic hepatocytes 
and nucleus with chromatin hyperchrome (apoptosis) may be 
related to the effects of quercetin and apigenin in producing 
apoptosis. Apigenin increases reactive oxygen species 
and causes production and release of cytochrome C from 
mitochondria into the cytosol and subsequently induction 
of procaspase-3 process, and finally apoptosis through rapid 
induction of caspase 3 activity and decrease in transmembrane 
potential (23). Although, antioxidant activity of the plants 
chemical compounds is well known (24) but under special 
conditions like high doses or presence of metal ions can reveal 
the perooxidants activity.
Furthermore, perooxidant or antioxidant activity of plant 
chemical compounds has near relationship with consumed 
concentration (25) that corresponds with liver pathologic 
lesions at doses of 1350 mg/kg. Studies on the cellular 
models have shown that some antioxidant polyphenols 
like quercetine, catechins (Epigallocatechin-3-gallate and 
epicatechin) and gallic acid have perooxidative activity (26). 
Also studies of Robaszkiewicz et al reported that high doses 
of quercetine (50 µmol) produce super oxide radicals in 
cultured cells and isolated mitochondria. In other studies, 
the antioxidant activity of quercetine has been  observed 
only at low doses (1 to 20 µmol)  whereas concentrations 
above 50 µmol can cause decrease in cell viability, thiol levels, 
the total antioxidant capacity and activity of superoxide 
dismutase, catalase and glutathione S-transferase (27). Studies 
of Watjen et al also showed that flavonoids (quercetine and 
fisetin) at low concentrations (10 to 20 µmol) protect H4IIE 
Class cells against cell toxicity, DNA breaks and apoptosis 
induced by hydrogen peroxide. Also, high concentrations of 
flavonoids (50 to 250 µmol) caused cell toxicity, demage to 
DNA and planned death (25). It has been proved that high 
concentrations of flavonoides increase production of reactive 
oxygen species by autooxidation (28). These cases show that 
consumption of high doses of lemon balm hydroalcohoic 
extract in the short period causes toxicity effects on liver cells. 
It seems that reduction in activity of antioxidant enzymes with 
internal origin in liver and kidney tissues in the groups treated 
with high doses of lemon balm extract may be responsible for 
tissue damages (27). Furthermore, reactive oxygen species, 
hydrogen peroxide, superoxide anion and hydroxyl radical 
are important intermediates of cell damage that can react 
to macromolecules such as lipids, proteins, nucleic acids, 
carbohydrates and unsaturated fatty acids in cell membrane 
and cause chain cell damage and death after the initial reaction 
(3). Studies have shown that a number of antioxidants such as 
quercetein and narinjenin can prevent activity of cytochrome 
enzymes (CYP1A1 and CYP3A4)   and cause cell damage (29). 
For this reason, various liver injuries was observed in 1.350 
mg/kg dose of lemon balm  group because liver has main 
and important role  in the different regulatory and metabolic 
pathways of drugs metabolism (activation and detoxification), 
excretion of exogenous and endogenous substances. Also 
changes of enzymes creatinine and urea are caused by lack of 
Melissa officinalis extract effect on kindy structures. 
Conclusion
According to enzyme and pathology results it can be concluded 
that consumption of lemon balam extract dose dependently 
causes toxicity in liver tissue.
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